Reuters logo
BRIEF-Evoke Pharma presents data from successful thorough ECG study of EVK-001
May 24, 2016 / 12:52 PM / a year ago

BRIEF-Evoke Pharma presents data from successful thorough ECG study of EVK-001

May 24 (Reuters) - Evoke Pharma Inc

* Evoke pharma presents data from successful thorough ECG (TQT) study of EVK-001 at digestive disease week 2016

* Data from phase 3 trial of EVK-001 for treatment of symptoms associated with diabetic gastroparesis in women expected early in Q3 of 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below